Clinical Trials
139 trialsDecisional Regret in Open Partial Horizontal Laryngectomy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
TACO
Centre Leon Berard
Identification of Pattern and Factors Affecting Recurrence in Head and Neck Carcinoma
Sohag University
Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto
SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome
Guy's and St Thomas' NHS Foundation Trust
COMRAD-HNSCC
Institute of Oncology Ljubljana
HYDRA
Erasmus Medical Center
Efficacy and Safety of TORS for SCCA
University of Virginia
Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma
Tongji Hospital
Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
National Cancer Centre, Singapore
Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
CZCNRHNSCC
Sun Yat-sen University
Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University
A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse
Centro di Riferimento Oncologico - Aviano
V-CHANCE
National Cancer Institute, Naples
B2023-153
Sun Yat-sen University
Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute
UPLIFT
Massachusetts General Hospital
Toripalimab in Combined With Cetuximab,Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC
First Affiliated Hospital of Zhejiang University
Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?
Luzerner Kantonsspital
Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
InGReS
Guy's and St Thomas' NHS Foundation Trust
NCCCNRHNSCC
Sun Yat-sen University
Sodium Selenite Supplementation in Patients With Head and Neck Cancer
Chang Gung Memorial Hospital
PRO-IMMUNO
University Medical Center Groningen
Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma (neoHNSCC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
Maastricht University Medical Center
iCHRTL
Maria Sklodowska-Curie National Research Institute of Oncology
Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis
Tampere University Hospital
Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma
Second Affiliated Hospital of Guangzhou Medical University
SPOKE
University Medical Center Groningen
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.
Assiut University
MRI - Guided Adaptive RadioTHerapy for Dysphagia in Head and Neck Cancer
Sichuan Cancer Hospital and Research Institute
The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute
PRINCESS
Fondazione del Piemonte per l'Oncologia
KOHACIN
Technical University of Munich
Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy
Peking Union Medical College Hospital
Oral Microbioma and Oral Malignant Disease
Academisch Ziekenhuis Maastricht
ORATOR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma
China Three Gorges University, Yichang, China
Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial
Second Affiliated Hospital, School of Medicine, Zhejiang University
QUASAR
University of California, San Diego
Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
PROBES
Nanfang Hospital, Southern Medical University
ACP-HN
Azienda Ospedaliero-Universitaria Careggi
CHANCE
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
USPIO-NECK
Radboud University Medical Center
MAG-NODE
Radboud University Medical Center